Laboratorios Quimica Son's, S.A. de C.V.

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED2 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• NO ENGLISH1 refused line

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

Questions about Laboratorios Quimica Son's, S.A. de C.V.

Is Laboratorios Quimica Son's, S.A. de C.V. on an FDA import alert?

No listing for Laboratorios Quimica Son's, S.A. de C.V. appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Mexico page.

Has FDA refused shipments from Laboratorios Quimica Son's, S.A. de C.V.?

Yes. FDA refused 2 shipment lines from Laboratorios Quimica Son's, S.A. de C.V. between September 22, 2022 and March 4, 2025. The most recent, on March 4, 2025, was vitamin b1 (thiamine), charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Laboratorios Quimica Son's, S.A. de C.V.'s shipments?

The most frequent charges are UNAPPROVED (unapproved new drug, 2 lines) and NO ENGLISH (required label information not in english, 1 line).

What is Laboratorios Quimica Son's, S.A. de C.V.'s FEI number?

Laboratorios Quimica Son's, S.A. de C.V.'s FDA Establishment Identifier (FEI) is 3012825182.